Results 141 to 147 of about 518 (147)
Some of the next articles are maybe not open access.

Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge

Avian Pathology, 2013
The Rispens (CVI988) vaccine is widely used to vaccinate chickens worldwide. We tested the protective effects of the Rispens vaccine against challenge with very virulent Marek's disease virus (vvMDV) at various intervals at, before or after vaccination. The experiment used commercial ISA Brown layers and vvMDV isolate 02LAR.
Tanzila, Islam   +4 more
openaire   +2 more sources

[Kinase domain analysis of MDV-1 CVI988/Rispens UL13 and preferred codon fragments expression in Escherichia coli].

Wei sheng wu xue bao = Acta microbiologica Sinica, 2009
To find catalytic center of MDV-1 UL13 and express it in vitro to investigate the function of UL13 kinase.UL13 gene was amplified by polymerase chain reaction (PCR) from MDV-1 CVI988/Rispens strain. The codon bias and antigenicity of UL13 in Escherichia coli was analyzed by online service GENEART (www.gcua.de)and DNAstar software respectively. Then the
Chenfei, Zhang   +6 more
openaire   +1 more source

Comparative 50% protective dose assays (PD) of Marke's disease virus strain CVI988

Journal of Biological Standardization, 1981
G F de Boer
exaly  

Home - About - Disclaimer - Privacy